Eton Pharmaceuticals, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ETON research report →
Companywww.etonpharma.com
Eton Pharmaceuticals, Inc. , a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.
- CEO
- Sean E. Brynjelsen
- IPO
- 2018
- Employees
- 31
- HQ
- Deer Park, IL, US
Price Chart
Valuation
- Market Cap
- $940.79M
- P/E
- -635.32
- P/S
- 10.82
- P/B
- 30.61
- EV/EBITDA
- 163.81
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 54.77%
- Op Margin
- 2.35%
- Net Margin
- -1.70%
- ROE
- -5.68%
- ROIC
- 3.10%
Growth & Income
- Revenue
- $79.95M · 104.94%
- Net Income
- $-4,601,000 · -20.35%
- EPS
- $-0.17 · -13.33%
- Op Income
- $72.00K
- FCF YoY
- 980.70%
Performance & Tape
- 52W High
- $34.47
- 52W Low
- $13.09
- 50D MA
- $25.16
- 200D MA
- $19.18
- Beta
- 0.82
- Avg Volume
- 416.28K
Get TickerSpark's AI analysis on ETON
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 21, 26 | RIEDEL NORBERT G | other | 19,655 |
| Apr 21, 26 | RIEDEL NORBERT G | other | 12,500 |
| Apr 21, 26 | RIEDEL NORBERT G | other | 12,500 |
| Apr 21, 26 | RIEDEL NORBERT G | other | 19,655 |
| Feb 3, 26 | RIEDEL NORBERT G | other | 30,000 |
| Feb 3, 26 | RIEDEL NORBERT G | other | 30,000 |
| Jan 12, 26 | RIEDEL NORBERT G | other | 7,757 |
| Jan 12, 26 | RIEDEL NORBERT G | other | 12,196 |
| Jan 12, 26 | Adams Jennifer McKie | other | 7,757 |
| Jan 12, 26 | Adams Jennifer McKie | other | 12,196 |
Our ETON Coverage
We haven't published any research on ETON yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ETON Report →